| 000 | 01575 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516104753.0 | ||
| 264 | 0 | _c20130125 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2012-2279 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSathyapalan, Thozhukat | |
| 245 | 0 | 0 |
_aAtorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cNov 2012 |
||
| 300 |
_a3951-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aMalondialdehyde _xblood |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xblood |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aShepherd, John | |
| 700 | 1 | _aCoady, Anne-Marie | |
| 700 | 1 | _aKilpatrick, Eric S | |
| 700 | 1 | _aAtkin, Stephen L | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 97 _gno. 11 _gp. 3951-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2012-2279 _zAvailable from publisher's website |
| 999 |
_c22013458 _d22013458 |
||